Desjardins Global Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-448
Closed -$32K 503
2022
Q1
$32K Sell
448
-28
-6% -$2.02K ﹤0.01% 439
2021
Q4
$43K Buy
+476
New +$56.9K ﹤0.01% 440

Other funds holding TDOC

Desjardins Global Asset Management's TDOC Position: Q2 2022 in Review

Desjardins Global Asset Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 448 shares — an estimated $32K sold.

Desjardins Global Asset Management first reported a position in TDOC in Q4 2021 and held it in 2 quarters. The position peaked at $43K in Q4 2021. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Desjardins Global Asset Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Desjardins Global Asset Management sold 448 Teladoc Health shares in Q2 2022, an estimated $32K.
  • Desjardins Global Asset Management first reported a position in Teladoc Health in Q4 2021 and held it in 2 quarters.
  • Desjardins Global Asset Management's Teladoc Health position peaked at $43K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Desjardins Global Asset Management's 13F filing for Q2 2022, filed 10 Aug 2022.